Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Barouch: Novel Vector/Protein Vaccines |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2014-06-25 |
| Study Made Public: | 2017-05-04 |
Title
Immunogenicity and antigenicity of variable loop optimized clade C gp140 Env trimers
Description
CAVD 457 is a preclinical guinea pig study of a biochemically stable HIV-1 Clade C (459C) gp140 Env trimer with epitope-optimized V2 and V3 loops.
Sign in to see full information about this study and to download study data.
Products
CpG DNA Env gp140 459C WT Env gp140 459C V2-Opt Env gp140 459C V2-Alt Env gp140 459C V2-Alt/V2-Opt Env gp140 459C WT/V2-Alt/V2-Opt Env gp140 459C V2-Opt Prime Env gp140 459C V3-Opt Env gp140 459C V3-Alt Env gp140 459C V3-Alt/V3-Opt Env gp140 459C V3-Opt Prime Env gp140 459C WT/V3-Alt/V3-Opt EMULSIGEN ® Env gp140 459C WT/V2-Alt Env gp140 459C WT/V3-AltIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.